Just recently, European researchers announced that MRI scans offer a new way to detect breast cancer in its earliest form. They can even prevent cancer among high-risk women.

Better than standard mammograms, MRI can detect a nonmalignant tumor called ductal carcinoma in-situ, or DCIS. Once found, the lesion can be surgically removed before it becomes cancerous.

Think about this: It is believed that almost all breast cancer starts out as DCIS. And this: if MRI were the gold standard breast cancer screening tool, we might be able to prevent a lot more breast cancer cases than we do now. It seems researchers agree.

My sister has skin cancer -- the basal cell variety. She has two spots, both on her chest, each one scheduled to be surgically removed in a few weeks. If it were me with this new diagnosis, I'm sure I'd be freaking out, maybe because I've already had breast cancer and tend to panic about any cancer or maybe just because I'm a worrier by nature. But my sister is taking her cancer news in stride, and I am too -- because now that I've done a little research, it seems this type of cancer is pretty easy to beat.

Here's a little refresher lesson on the skin: The skin is the largest organ in the body, and is made of three layers -- the epidermis (top layer), dermis (middle layer), and subcutis (deepest layer). For the purpose of this post, let's focus on the epidermis.

The epidermis has three layers -- an upper, middle, and a bottom layer. This bottom layer is comprised of basal cells. This is where basal cell cancer begins.

I did a post back in August of last year about my friend Larissa's journey through breast cancer. Larissa was just recently diagnosed with cancer again. This time it was skin cancer, basal cell carcinoma.

I asked Larissa if she would talk about her experience and how it felt to be diagnosed with cancer yet again. Larissa blogs at Welcome to the Dallehouse.

How did you find out you had skin cancer?

I had a red patch on my face that didn't go away for several months. I kept an eye on it and noticed it was getting larger so I made an appointment with a dermatologist. The dermatologist thought it looked suspicious and did a shave biopsy. The biopsy came back positive for basal cell carcinoma.

David Foster was diagnosed with Advanced Renal Cell Carcinoma in April 2005. Translation: stage four kidney cancer and the sixth deadliest form of cancer. Not a great disease to acquire. Also not the end of the world. Just ask David who is busy working as a National Strategic Advisor in Augusta, Georgia, headlining within the independent magazine community, hanging out with dog Gracie, and documenting his journey in a blog he calls David Foster's Kicking Kidney Cancer's Arse.

He's no wimp, this guy. Just read his June 23 post, titled May kill me, but it ain't gonna beat me. He didn't let that hard-nosed kid Jerry whip him when he was eight -- he smacked him so hard in the lunchroom, Jerry was left stumbling and bleeding -- and he won't let cancer bully him either. Still, David admits: he is sick. He explains it all in a post he calls Mr. Foster, are you really sick?

David got an e-mail one day. It read, Mr. Foster, are you really sick? I read your blog and you don't sound sick.

Magnetic resonance imaging (MRI) showed in a study presented at the 2007 annual meeting of the American Society of Clinical Oncology to be better at detecting ductal carcinoma in situ (DCIS) than mammograms. MRI's were also shown to be very good at detecting high grade DCIS.

Women are recommended by the American Cancer Society to get an annual mammogram after the age of 40, do clinical breast exams starting in your 20's and if you are in a high risk group to receive annual screening with a breast MRI.

In a study among almost 6,000 women who were screened with both MRI and mammography, MRI detected 92 percent of DCIS cases where mammography only detected 56 percent of cases diagnosed.

New cancer drug Torisol was approved on Wednesday by the FDA for use with renal cell carcinoma, an advanced form of kidney cancer.

Torisol, also known as temsirolimus, is an enzyme inhibitor made by Wyeth Pharmaceuticals and has shown promise for prolonging patient survival. It's the third kidney cancer drug approved in the past 18 months -- the other two are Nexavar, intended to delay disease progression, and Sutent, for tumor size reduction.

Many kidney cancer patients are cured by surgery. About 35 percent of patients, however, experience a recurrence or a spread of the disease. Until just recently, there were no effective drugs to control these issues. Now there are several -- and Torisol is the one showing modest improvement in survival for patients with the most advanced tumors. Further study will indicate whether or not the drug is useful for patients with less extensive metastatic disease.

Interferon is an immune stimulating agent. According to an article recently published in the Annals of Surgery, administration of interferon following surgery may improve survival among patients with advanced hepatitis B-related hepatocelluar carcinoma.

Hepatocelluar carcinoma (HCC) is the most common type of liver cancer. Unfortunately for this disease, recurrences often happen after surgical removal of the cancer. Researchers continue to evaluate ways to reduce these recurrences.

A clinical trial was conducted to evaluate the use of interferon following surgery in patients with HCC. The trial included 80 patients, one group received the interferon after surgery and the other group received no further treatment. The researchers found that the group treated with interferon experienced better survival rates.

UK researchers have developed a 3D laboratory model of human breast cancer, specifically ductal carcinoma in situ (DCIS). The model, complete with normal cells and tumor cells, should help experts understand how the disease develops in its early stages, and it could replace the need for experiments in animals.

About one in five breast cancers in the UK start out as DCIS. Researchers wanted to learn more about how the early cancerous changes in cells develop into larger tumors, and they chose to fashion a 3D test tube model because it is more complex than a layer of cells in a Petri dish.

Once this experiment is proved successful, it could reduce and perhaps replace animal studies.

"With breast cancer, there is an urgent need to move away from animal research models because their similarity to human cancer can be so poor," says one expert who explains this model could help revolutionize breast cancer research -- because unreliable research costs time, money, and lives, both animal and human lives.

Those who drink one or two cups of tea daily may have a lower risk of developing two types of skin cancer by 20 to 30 percent. In a study conducted on nearly 2,200 adults, researchers found that tea drinkers had a lower risk of developing squamous cell and basal cell carcinoma, the two most common forms of skin cancer.

The findings were published in the Journal of the American Academy of Dermatology.

Tea drinking did not show any effect on the worst skin cancer, melanoma. Still, the findings support the theory that tea antioxidants may limit the damage UV radiation inflicts on the skin, according to the study authors, led by Dr. Judy R. Rees of Dartmouth Medical School in Lebanon, New Hampshire.

The researchers do warn that it is not okay to bake in the sun and then have a cup of tea afterwards.

The study did not mention what specific types of teas might be more beneficial than others.

UVB radiation is thought to be the most dangerous light in the solar spectrum. Scientists think that UVB light causes most of the non-melanoma skin cancers.

When you're exposed to UVB radiation for a period of time, it inflames the skin and causes sunburn. Squamous cell carcinoma is diagnosed in about 250,000 people each year in the United States. The cancer can arise from the inflammation of the skin by possible DNA damage.

Even though the scientist's discovery was only so far seen in mice, the researchers at the Ohio State University Medical Center say that a topical compound made of black raspberries significantly slows the growth of Squamous cell skin cancer.

The scientists think that the cancer fighting effects are a result of powerful antioxidants called anthacyanins that give the fruit its rich, dark color. The researchers said "In our experiments, the black raspberry treatment significantly reduced inflammatory damage and reduced tumor growth and spread".

In the future the researchers hope to have a topical treatment for humans that will alleviate pain and also protect against sun damage.

It's been a rough road for former Boise State basketball player Coby Karl, son of Denver Nuggets coach George Karl. The younger Karl, 23, had his thyroid removed 13 months ago due to papillary carcinoma, a treatable form of cancer. And he returned to the operating room just last week for the removal of cancerous lymph nodes.

Karl's recent surgery, intended to take two to three hours, lasted for seven hours. This worried Dad.

''When it goes longer and longer, you always think the worst, and start worrying about things like being under anesthesia that long and all the nightmares you have about surgeries,'' George Karl said.

But it turns out Coby was just fine -- doctors just wanted to be thorough -- and the ambitious young man plans to play ball as soon as possible.

Coby is expected to remain inactive for 10 days to two weeks. But after that, he is free to do whatever he wants. And what the 6-foot-4 guard wants to do is start working out in hopes of getting drafted by an NBA team.

''He is anxious to get into the NBA thing and celebrate basketball by trying to make it in this league,'' his dad says.

Denver Nuggets coach George Karl missed his team's match-up against the Lakers Tuesday night so he could spend some quality time with his son, Coby, who had surgery for the removal of cancerous lymph nodes on Monday.

Coby Karl, 23, spent seven hours in surgery. It was his second surgery in 13 months -- he had his thyroid removed last year after he was diagnosed with a treatable form of cancer called papillary carcinoma. Chemotherapy followed the first surgery to kill off any remaining cancer cells.

All reports indicate both Karls are doing fine and Coach Karl, who has been surviving prostate cancer since 2005, was back to his coaching duties last night. His team took on the Sacramento Kings -- and won.

Coby Karl is taking it easy for now. He just recently finished his final season with Boise State University where he led the Broncos with 14.8 points per game. He's still a great athlete, but right now, his health comes first.

"He's a young kid, he's a promising basketball player," Lakers coach Phil Jackson said. "The most important thing is his health."

Boise State basketball player Coby Karl, son of Denver Nuggets coach George Karl, had surgery 13 months ago to remove his thyroid after he was diagnosed with papillary carcinoma, a form of treatable cancer. And while Karl received chemotherapy to kill off any lingering cancer cells, he must undergo cancer surgery once again.

Karl, who plans to play in the NABC All-Star game in Atlanta on March 31, will return to Boise on April 2 for surgery to remove cancerous lymph nodes.

The lymph node cancer was identified in January, but Karl, 23, kept his condition private until his team lost to New Mexico State in the Western Athletic Conference tournament semifinals. This ended the Broncos' season. And now begins Karl's second go-round with cancer.

You may remember Karl as one of last year's NBA draft hopefuls. He worked out for three teams, including his dad's team, but eventually withdrew his name from the draft and returned to Boise State for his senior year.

I blogged about Diagnosis of triple-negative breast cancer back in November. This topic seemed to get many responses from women who fit into this breast cancer 'category'.

I read a report today that discussed new data that can add to the traditional pathology testing, tumor size and lymph node status to name a few, for women with triple negative disease. This would not be a new treatment for triple negative breast cancer, but I believe this information found to be very important for future discoveries that might lead to more options for triple negative breast cancer patients.

What was discussed was the assessment of basal cytokeratins and androgen receptors in patients with triple negative breast cancer. The researchers are trying to identify prognostic markers that might signal more aggressive behavior of these specific tumors.

The only thing this seems to be able to help with at the moment is getting physicians to understand if you have a triple negative breast cancer that is more aggressive, thus warranting more aggressive treatment.

For those with triple negative disease this might not seem that great, however they are studying what makes these tumors tick and I think this will eventually evolve into new targeted treatments.

Watching the Superbowl yesterday made me think of Brian Piccolo. Brian played for the Chicago Bears from 1965 until 1969. He was diagnosed with embryonal cell carcinoma, it was almost 100% fatal at the time of his diagnosis. Sadly, Brian Piccolo died on June 16, 1970 at the age of twenty six, leaving his wife and three daughters.

Chicago mourned the death of Brian Piccolo and he became a legend when the television movie Brian's Song was released in 1971. I remember the showing of that movie in my grade school years. There wasn't a dry eye in the auditorium.

Bears running back, Gale Sayers uttered these famous words in May 1970, as he accepted the NFL's most Courageous Player award. Sayers told the crowd that they had selected the wrong person for the honor, and would accept it only on Piccolo's behalf. He said " I love Brian Piccolo, and I'd like all of you to love him. When you hit your knees to pray tonight, please ask God to love him, too".

After Piccolo's death, the Brian Piccolo Cancer Research Fund was established, and millions of dollars have been donated to the cause of finding a cure to various forms of the disease. Thanks in part to those funds raised in the Piccolo's name, with early detection and treatment, this disease is now almost completely curable.

There are also a few books you can read about Brian:

Brian Piccolo, A Short Season

Gale Sayers' autobiography I am Third.